In addition, studies have suggested that HDAC1 inhibits miR-34a expression directly or indirectly [15, 16] and down-regulation of miR-34a plays an important role in the pathogenesis of PAH [17, 18]. Here, HDAC1 is linked to pulmonary arterial hypertension.